Defibrotide是哪里生产的？

Defibrinoside () is suitable for: adults and children with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), and renal or pulmonary dysfunction after hematopoietic stem cell transplantation (HSCT). Some patients have asked where Defibrotide is produced. Here is the answer: Defibrotide is produced by Jazz Pharmaceuticals Public Limited.

Company (NASDAQ: JAZZ) was founded in 2003 and is headquartered in Dublin, Ireland, with 885 full-time employees. It is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of pharmaceutical products. Jazz Pharmaceuticals is a professional biopharmaceutical company mainly engaged in the participation, research and development and sales of various medical drugs in the United States, Europe and internationally. Jazz Pharmaceuticals' products include: JZP-110 - for the treatment of patients with narcolepsy (EDS) - clinical stage; JZP-386 - sodium oxybate product, an improved deuterium analogue, for the treatment of narcolepsy - clinical stage; Asparec - for the treatment of acute lymphoblastic leukemia (ALL) and Escherichia coli-asparagus Amine Hypersensitivity - Phase I clinical trial; - For the treatment of severe hepatic veno-occlusive disease (VOD) - Clinical trial; Leukotac - An anti-CD25 monoclonal antibody for the treatment of steroid-refractory acute graft-versus-host reaction - Phase III clinical trial.